IFM 99-02 Thalidomide in Myeloma
|2||Active, not recruiting||
Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma
GEM05 for Patients With Multiple Myeloma Under 65 Years
VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma
Busulfan and Melphalan Conditioning in Multiple Myeloma
Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.
† Indicates status has not been verified in more than two years